chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Bleeding at site when shot was given. Dizziness within 5 minutes & continued for a couple of hours. (I stayed well hydrated & did eat) By 4:00 pm  swelling in left arm approximately  16 cm long & 6 cm wide almost 2cm higher than rest of skin.  Visible bruising at shot site.   I applied PanAway essential oils to help rid inflammation.   10:00 pm Friday 2/26, chills & body aches begin & were not subsided with drinking hot water. I went to bed. Fitful sleep.  Random boughts of chills & sweats throughout night. Body aches?muscle pain & fatigue, joint pain. Severe pain in left arm, shoulder, armpit, left side of neck.   Around 10:00-10:30 am everything from my waist up hurt.  Bone & muscle pain, difficult to lift limbs, lymph nodes swollen, severe jaw, neck, & head pain. 3:30 pm only my head, neck, jaw, sinuses hurt..  I got out of bed, ate, & took Tylenol Sinus.  It helped with pain.  I could walk without pain. Site swollen, red rash that itches about 16cmx 9 cm continues today 3/1/21.
Patient was given first COVID vaccine for a 9:45AM appointment by a certified immunizing pharmacy technician. The vaccine was given approximately around 10:00AM and was seated for 15 minutes in pharmacy waiting area after vaccine. At Around 10:15AM patient reported feeling very itchy all over his body, he felt his throat feeling a little tight, and his tongue felt swollen. Paramedics were called and on their way. Patient refused an EpiPen. Paramedics arrive on site around 10:30AM and took the patient with them..
on 9-16-20 about 30 minutes after the injection, injection site started itching, burning and turning red. from that time, arm began to swell at the injection site and swelling and redness progressed over the next 48 hours down to elbow and underneath arm. patient went to clinic for treatment on 9-17-20 in the am and was given triamcinolone cream 0.1% to apply twice a day  and prednisone tablets 20mg twice a day for 3 days. and benadryl 25mg every 6 hours as needed. pt used all these medications and symptoms began to resolve on 9-19-20 and gradually improved until now. no swelling now, injection site is just bruised looking.
Administration error, Patient was supposed to receive pfizer covid vaccine but received fluarix. She had already received a flu vaccine for this season. Covid vaccine was administered in opposite arm.
Covid-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Covid-19) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     Concurrent medical conditions included Multiple sclerosis. Concomitant products included OCRELIZUMAB (OCREVUS) for an unknown indication.   In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Dec-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced COVID-19 (Covid-19). At the time of the report, COVID-19 (Covid-19) was resolving. Not Provided          No treatment information was provided.  Company Comment: This spontaneous case concerns a 31-year-old, female patient with relevant medical history of administration of Ocrevus (ocrelizumab), who experienced the unexpected, non-serious AESI of COVID-19. The event occurred approximately 1 month after administration of the third dose of the Moderna mRNA-1273 vaccine. No further details were provided. Treatment information was also not provided. However, the event was resolving at the time of the report. The medical history of administration of Ocrevus, which is an immunosuppressive drug used for the treatment of Multiple Sclerosis, remains a confounder. The benefit-risk relationship of the Moderna mRNA-1273 vaccine is not affected by this report.; Sender's Comments: This spontaneous case concerns a 31-year-old, female patient with relevant medical history of administration of Ocrevus (ocrelizumab), who experienced the unexpected, non-serious AESI of COVID-19. The event occurred approximately 1 month after administration of the third dose of the Moderna mRNA-1273 vaccine. No further details were provided. Treatment information was also not provided. However, the event was resolving at the time of the report. The medical history of administration of Ocrevus, which is an immunosuppressive drug used for the treatment of Multiple Sclerosis, remains a confounder. The benefit-risk relationship of the Moderna mRNA-1273 vaccine is not affected by this report.
getting sick; dizzy; weak; tired; sore throat; headache; chills; fever; everything stopped--my normal activity except going to work; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 32 year-old male patient received bnt162b2 (BNT162B2), administration date 11Aug2021 (Lot number: EW0198) as dose 2, single for covid-19 immunisation. Relevant medical history included: "Appendix removal" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (1st dose, Lot EW0181), administration date: 21Jul2021, for COVID-19 immunisation, reaction(s): "Tiredness", "not in the mood of doing anything". The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "getting sick"; DIZZINESS (non-serious), outcome "unknown", described as "dizzy"; ASTHENIA (non-serious), outcome "unknown", described as "weak"; FATIGUE (non-serious), outcome "unknown", described as "tired"; OROPHARYNGEAL PAIN (non-serious), outcome "unknown", described as "sore throat"; HEADACHE (non-serious), outcome "unknown", described as "headache"; CHILLS (non-serious), outcome "unknown", described as "chills"; PYREXIA (non-serious), outcome "unknown", described as "fever"; LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (non-serious), outcome "unknown", described as "everything stopped--my normal activity except going to work". Therapeutic measures were taken as a result of fatigue, oropharyngeal pain, headache.  Follow-Up (07Sep2021): Follow-up attempts are completed. No further information is expected.
Pneumovax vaccine 0.5 to right deltoid on 5/1/06 12pm pt noted pain at infection site that evening and warmth no fever and erythema deltoid, right axilla. returned to clinic 5/2. Cephalexin 500 QID 10d, Codeine PRN.
Patient was given the first dose of Moderna on 03/5/21 and upon getting the second dose today 04/02/21 she informed the pharmacy she had cellulitis after the first dose and was hospitalized for over a week.
76-year-old female, who presents to Hospital on 2/8/22 with cough, shortness of breath, wheezing.  The patient was diagnosed with coronavirus pneumonia and found to have acute hypoxic respiratory failure.  She has a history of atrial fibrillation for which she is on Xarelto 20 mg per day.  She has a history of chronic obstructive pulmonary disease for which she takes albuterol as needed.  She has a history also of diabetes mellitus, last hemoglobin A1c of 6.4.  Discharged 2/11/22  Pfizer 2/22/21, 3/16/21
I had a sore arm for a few days following the injection, which was to be expected. Today, however, exactly one week post injection, I noticed some itching at the injection site. Upon visualization, there is an area of localized small raised and reddened areas at the injection site.  There is also warmth present at the site of injection.
9:02am rec'd vaccine  approx 9:10am - severe itching that started on the left side and crossed over to the right side and included small hives on my chest 9:38am, I took 2 - 25 mg benadryl tablets advised by the nurse at the testing center approx 10am, the itching was worsening and was advised to take another 25mg benadryl approx 10:10am was feeling relief and left the vaccine distribution site 10:45 am arrived home and and slept for the rest of the day experienced arm soreness for 4 days post vaccine
Mild to moderate fever, chills, headache, body aches, fatigue.  Beginning with mild chills which started about 8 hours after receiving vaccine. Remainder of symptoms started about 16 hours after receiving vaccine. Symptoms lasted about 36 hours after receiving vaccine, fatigue lasting longest. After 36 hours, symptoms resolved.
Herpes Zoster in a previously vaccinated individual. Painful, unilateral, 1 dermatome rash lasting less than 4 weeks. Onset of 8/7/2017. VALTREX was given to the patient
COVID-19 confirmed by positive COVID-19 test; COVID-19 confirmed by positive COVID-19 test; This is a spontaneous report from a contactable female consumer (patient) from a Pfizer-sponsored program COVAX US Support.  A female patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient tested covid positive on 07Jan2021, after she got her first dose of pfizer covid vaccine. The outcome of the event was unknown.   Information on the Lot/batch number has been requested.
Side effects; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Side effects) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Side effects). At the time of the report, VACCINATION COMPLICATION (Side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant drugs were reported. No treatment drugs are not provided by reporter.
MINOR DISCOMFORT IN ARM FIRST DAY.  AROUND 12PM ON 2ND DAY, EXPERIENCED INTERMITTENT CHILLS WITH SHAKING, THEN FEVER OF 102+, WITH NAUSEA AND FOREHEAD AND FACE VERY RED.   ON 3RD DAY MORNING FEVER OF 102 WITH HEADACHE, BUT FEVER BROKE THAT MORNING AROUND 8AM TO 99 AND HEADACHE LEFT.  INJECTION SITE WAS NEVER RED BUT FELT VERY WARM ON THE 2ND DAY.   (NOTE:: HAD ANTIGEN INFUSION ON DECEMBER 9, 2020, AT  HOSPITAL.)
The area at the injection site was red, swollen, with a hard lump, and tender to touch per patient. She stated reaction started with in 24 hrs of injection. She could not take IBU b/c she has a history of ulcers. She is going to call MD in AM if not better. She said she did not have a fever.
Arthus phenomenon in the left deltoid and the left subcutaneous tissue (localized to the injection sites). Only had mild erythema, swelling, and warmth at the location of injection.
Patient received first vaccine (12.29.20) and experienced injection site reaction for 3 days. 10 days later the redness and tenderness re-appeared. The area is approximately 1.5 by 1.5 inches, somehwat round "wheal" urticarial center. Patient has been taking benadryl for symptom relief with little change in symptoms or appearance. No other complaints.
Vertigo 26 days after injection. Was hospitalized 10/27 at 10:15 after getting violently dizzy at home with chest pain.
Less than 10 days after the vaccine, I had acute pain in my MCPs and MTPs. I saw my primary care doctor approximately 10 days after the pain started. Bloodwork was normal, but she referred me to a rheumatologist who diagnosed me with rheumatoid arthritis. Despite beginning medication, pain is ongoing. I know 3 other women in my age group who are experiencing the same symptoms and are awaiting to see a rheumatologist. I strongly suspect a vaccine-related AE, either from this years flu vaccine, the Covid booster, or receiving the two in close proximity.
In Oct90 10 out of 59 pts were found to have either insuff. or neg antibody levels during post serology testing of anti-HBs.  (see also EBU910169 - EBU910177).
Information has been received from a nurse referring to an unspecified patient of unknown age and gender. On 02-NOV-2015 the patient was vaccinated with improperly stored (Oka-Merck) PROQUAD (lot # L009208, expiration date 17-SEP-2016, dose and route unspecified). No adverse effects reported. This is one of several reports received from the same source. Additional information has been requested.
Mom states that patient had fever that was 104.0*F on Saturday, 10/31/15 and continued to have intermittent fever until Sunday afternoon, 11/1/15.
Vaccines were administered as ordered on 5/13/3031. After administration, the nurse who had given the vaccines found that the MMR vaccine that was given had expired on 5/9/2021. The patient's mother was informed of the event and was advised to monitor for any adverse reactions. The patient's mother has been contacted daily since the administration of the vaccine and has denied any signs or symptoms of any adverse reactions.
1)Frontal/temporal headache. 2)prickly, tingling sensation of inner and outer upper lip and tongue.  3)hypersensitivity of mouth and tongue. 4) 1/4 inch red spot with soreness left side of tongue.  5) hives right arm, raised, not red or itchy. All the above symptoms occurred within 25-30 minutes of injection. Day 5 pain L hip ongoing but not as acute as day 5. Day 9 Soreness at injection site, raised, no redness; generalized achiness, slight nausea.
8 days post vaccine I passed out (vaso vagul syncopy episode) my blood pressure plummeted and I blacked out About 9-10 days post vaccine started getting heart palpitations, racing heart beat, felt like my heart was being squeezed and someone was trying to pull my heart out of my chest. My sternum hurt so bad I felt like I was having a heart attack.  12 days post vaccine I was still feeling very weak and lightheaded all the time and felt like another episode was coming on. I was incredibly nauseous and couldnt get any food down. Lost a few pounds that week because was so nauseous I couldnt eat. Had complete loss of appetite. Was so lightheaded and constantly dizzy when I stood up and tried to walk. Had horrible GI abdominal cramps and had 7 days of yellow diarrhea. Started having tingling in my left hand and fingers and started creeping up. Brain fog. Horrific migraines for 8 days straight. Shivering/chills. Had a hard time with temperature regulation. Could barely walk, couldnt drive, couldnt take care of my toddler.   Diagnosed with auto immune disease, Chronic inflammatory response syndrome, SIBO/SIFO, brain inflammation
Itchy spot on / his left arm where he got the vaccine; Itch in his scalp / daily / a new itchy spot on his scalp / or his right arm / is intermittent; This case was reported by a consumer via call center representative and described the occurrence of injection site itching in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 20th January 2021, the patient received the 1st dose of Shingrix (intramuscular). In January 2021, less than 2 weeks after receiving Shingrix, the patient experienced injection site itching and itchy scalp. On an unknown date, the outcome of the injection site itching and itchy scalp were not recovered/not resolved.   It was unknown if the reporter considered the injection site itching and itchy scalp to be related to Shingrix.  Additional details were provided as follows: The case was reported by the patient himself. The patient received the 1st dose of Shingrix.  He stated that 3 to 4 days after getting the vaccine, the patient began to itch in his scalp, but the itching resolved.  The patient daily get a new itchy spot on scalp, his left arm where he got the vaccine or his right arm. The itching was intermittent, and always resolves, but reoccurs randomly.  The reporter did not wish to provide his health care professionals information. The reporter did not consent to follow-up.
Soreness; Nause; Fever; Headaches; Muscle Hurts; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Soreness), NAUSEA (Nause), PYREXIA (Fever), HEADACHE (Headaches) and MYALGIA (Muscle Hurts) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 22-Feb-2021, the patient experienced PAIN (Soreness), NAUSEA (Nause), PYREXIA (Fever), HEADACHE (Headaches) and MYALGIA (Muscle Hurts). On 24-Feb-2021, PAIN (Soreness), NAUSEA (Nause), PYREXIA (Fever), HEADACHE (Headaches) and MYALGIA (Muscle Hurts) had resolved.            No relevant concomitant medications were reported. Treatment medicine include Extra Strength Tylenol
Gave patient first dose of COVID-19 vaccine, and the vaccination was 1 day past BUD. BUD was set for 06/26/2021, vaccination was administered 06/27/2021. Spoke with Patient on 06/28/2021, patient is fine, not experiencing side effects, etc. Patient was understanding as we are waiting to hear back from Moderna regarding efficacy of dose administered.
Patient presented with redness, hives, itching, and swelling on right side of face and near injection site after receiving the vaccine 1 hour prior.
My mother had her second Covid vaccine on Wednesday. Had been feeling fine prior to getting injections. After receiving second injection she complained of her arm hurting. No one talked to her after that night I went to check on her Friday morning and she was deceased. Autopsy was performed and there still has been no known cause of death the only thing that makes sense would be the vaccine took her life.
EXPECTED SIDE EFFECTS; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced expected side effects. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from expected side effects. This report was non-serious.
33 Y F with a PMHx of severe alcohol use disorder, bulimia, multiple hospital admissions for alcoholic withdrawal & alcohol hepatitis, most recent admission 11/2021 for mallory weiss syndrome and alcohol withdrawal was admitted on 12/31/21 for alcoholic hepatitis and abdominal wall cellulitis. S/p paracentesis x 2 (12/31/21 removed 4L, and 1/2/22 removed 2.4L). Was found to have covid exposure at home, tested positive on 1/2/22.    On admission, her Maddy Discriminant Function 45.1 indicating poor prognosis. She was treated for alcoholic hepatitis with steroids and finished 7 day course, with favorable lille score, thus continuing prednisolone for 30 day course. She was also empirically treated for cellulitis of abdomen with CTX for 7 days. SBP was ruled out based on paracentesis studies and CT A/P. Patient has received 2 paracentesis during hospitalization as above. Course complicated by leaking peritoneal fluid despite pressure packing, and was ostomy bag was placed, patient continued to peak, but spontaneously resolved without further intervention. Patient had ultrasound of abdomen 1/8/22, which did not show a tappable ascitic pocket.   On admission, she was noted to have tachypnea and tachycardia. Her father is positive for COVID, she tested positive on 1/2/22. She is s/p 5 days of remdevisir for covid and was already on steroids for alcoholic hepatitis.  She was also noted to be strongyloides positive, and after discussion with ID, patient will get ivermectin prior to discharge.   For her occasional black stools, case was discussed with GI, and patient is medically managed with protonix. Her black stools resolved, and her H/H has been stable.
swelling, redness, warm from inj site-RD down to elbow 30JUN95;
First dose on 4/8/2021 had very small (about size of a coin) red area around injection location for a few days. Second dose on 5/6/2021 produced much larger (about size of a softball) red area with significant sensitivity and slight itch.
no adverse event; HCP calling to report AE for patient that was given additional dose of PROQUAD instead of VAQTA.  Administered dose was on 10/13 but MNSC notified today.  Confirmed VAQTA not administered to patient, just PROQUAD.  No adverse reactions noted.  No add; HCP calling to report AE for patient that was given additional dose of PROQUAD.; This spontaneous report has been received from a nurse, referring to a 13-year-old female patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported.  On 13-OCT-2023, the patient received an additional dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) injection, single dose, lot #X009130, expiration date: 24-SEP-2024, administered for prophylaxis (strength, and route of administration were not provided) instead of hepatitis a vaccine, inactivated (VAQTA) intramuscular injection, administered for prophylaxis (strength, lot #, expiry date, and route of administration were not provided) (wrong product administered, extra dose administered).   It was confirmed that hepatitis a vaccine, inactivated (VAQTA)was not administered to patient, just measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) dose. No adverse reactions noted. No additional adverse events (No adverse event).
ADMINISTERED COVID VACCINE (MODERNA 1ST DOSE) TO PT ON 5/14.  PT WORKS IN THE STORE AND WAS ON HER WAY TO THE BACK OF THE STORE WHEN SHE NOTICED A CLEAR LIQUID RUNNING DOWN HER ARM FROM THE VACCINE ADMIN SITE.  PT THEN TOOK OFF THE INJECT-SAFE BANDAGE AND SAID THERE WAS A CLEAR LIQUID POOLING IN THERE AS WELL.  FROM THE DESCRIPTION, IT SEEMED THAT THE MAJORITY OF THE ADMINISTERED VACCINE LEAKED BACK OUT.  PER RESEARCH FROM MODERNA/CDC, IT IS ADVISED THAT PT RECEIVE THE DOSE AGAIN, IN THE OPPOSITE ARM.  PT WAS INFORMED ACCORDINGLY.